|
注册号: Registration number: |
ChiCTR1800017690 |
|
最近更新日期: Date of Last Refreshed on: |
2018-08-09 17:47:21 |
|
注册时间: Date of Registration: |
2018-08-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
经会阴与经直肠局部麻醉在经直肠前列腺穿刺活检中的临床价值 |
|
Public title: |
Clinical value of transperineal and transrectal local anesthesia in transrectal prostate biopsy |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
经会阴与经直肠局部麻醉在经直肠前列腺穿刺活检中的临床价值 |
|
Scientific title: |
Clinical value of transperineal and transrectal local anesthesia in transrectal prostate biopsy |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
王鲲鹏 |
研究负责人: |
王鲲鹏 |
|
Applicant: |
Wang Kunpeng |
Study leader: |
Wang Kunpeng |
|
申请注册联系人电话: Applicant telephone: |
+86 18961325365 |
研究负责人电话:
Study leader's |
+86 18961325365 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
wangkp0216@126.com |
研究负责人电子邮件: Study leader's E-mail: |
wangkp0216@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
江苏省连云港市海州区振华东路6号 |
研究负责人通讯地址: |
江苏省连云港市海州区振华东路6号 |
|
Applicant address: |
6 Zhenhua Road East, Haizhou District, Lianyungang, Jiangsu, China |
Study leader's address: |
6 Zhenhua Road East, Haizhou District, Lianyungang, Jiangsu, China |
|
申请注册联系人邮政编码: Applicant postcode: |
222061 |
研究负责人邮政编码: Study leader's postcode: |
222061 |
|
申请人所在单位: |
连云港市第一人民医院 |
||
|
Applicant's institution: |
The First People's Hospital of Lianyungang City |
||
|
研究负责人所在单位: |
连云港市第一人民医院 |
||
|
Affiliation of the Leader: |
The First People's Hospital of Lianyungang City |
||
|
是否获伦理委员会批准: |
否 |
||
|
Approved by ethic committee: |
No |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
伦理委员会批件附件: Approved file of Ethical Committee: |
||
|
批准本研究的伦理委员会名称: |
|
||
|
Name of the ethic committee: |
|
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2013-08-26 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
连云港市第一人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First People's Hospital of Lianyungang City |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
江苏省连云港市海州区振华东路6号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
6 Zhenhua Road East, Haizhou District, Lianyungang, Jiangsu, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
连云港市第一人民医院青年英才基金 |
||||||||||||||||||||||
|
Source(s) of funding: |
Lianyungang First People's Hospital Youth Talent Fund |
||||||||||||||||||||||
|
研究疾病: |
前列腺癌 |
||||||||||||||||||||||
|
Target disease: |
Prostate cancer |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
治疗新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
New Treatment Measure Clinical Study |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
采用随机、对照、双盲的研究方法,选取一定数量的前列腺穿刺活检患者,比较经会阴局麻阻滞与经直肠局麻阻滞对经直肠前列腺穿刺患者疼痛耐受性的影响,采用疼痛评分表进行评分,运用卡方检验进行统计学分析,进而指导临床,使患者获益,节约医疗资源。 |
||||||||||||||||||||||
|
Objectives of Study: |
A randomized, controlled, double-blind study was conducted to select a number of prostate biopsy patients to compare the effects of perineal local anesthesia and transrectal local anesthesia on pain tolerance in patients undergoing transrectal prostate puncture. Visual analogue score was scored, and the chi-square test was used for statistical analysis to guide the clinic, benefit the patients, and save medical resources. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
①有明确前列腺癌病史; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. has a clear history of prostate cancer; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2018-08-15 00:00:00至 To 2021-06-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2018-08-15 00:00:00 至 To 2021-06-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男性 |
Gender: |
Male |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
运用随机表进行随机、对照、双盲的研究方法 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Random, controlled, double-blind research methods using random tables |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
Not stated |
|
Blinding: |
Not stated |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
手工输入 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Manual input |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form, CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |